J Korean Soc Laryngol Phoniatr Logoped.  2020 Jun;31(1):7-12. 10.22469/jkslp.2020.31.1.7.

Prevention and Adjuvant Therapy of Recurrent Respiratory Papillomatosis

Affiliations
  • 1Department of Otolaryngology-Head and Neck Surgery, Dong-A University College of Medicine, Busan, Korea

Abstract

Recurrent respiratory papillomatosis (RRP) is characterized by repeated recurrence in the respiratory system, such as the pharynx, larynx, and trachea, caused by the human papilloma virus. The main treatment is surgical removal of the papilloma. However repeated recurrence of RRP in multiple areas is burdened for the surgeon. In addition to the surgery, various adjuvant therapies have been studied to reduce the recurrence. Literature review was conducted with a focus on the adjuvant treatments for RRP.

Keyword

Adjuvants; Human papillomavirus; Recurrent respiratory papillomatosis; Papillomavirus Vaccines; 보조요법; 인유두종바이러스; 재발성 호흡기 유두종증; 유두종바이러스 백신
Full Text Links
  • JKSLPL
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2022 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr